Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $288.33 | 4 | 59.3% |
| Education | $166.52 | 6 | 34.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.25 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seattle Genetics, Inc. | $190.60 | 4 | $0 (2018) |
| Incyte Corporation | $114.97 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $98.17 | 1 | $0 (2017) |
| PFIZER INC. | $31.25 | 1 | $0 (2018) |
| Seagen Inc. | $26.22 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $12.97 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $26.22 | 1 | Seagen Inc. ($26.22) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2018 | $317.80 | 6 | Seattle Genetics, Inc. ($190.60) |
| 2017 | $130.16 | 3 | E.R. Squibb & Sons, L.L.C. ($98.17) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2022 | Seagen Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $26.22 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/12/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 09/11/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 08/03/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $158.17 | General |
| Category: Oncology | ||||||
| 06/30/2018 | PFIZER INC. | BOSULIF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $31.25 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/12/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $7.85 | General |
| Category: Oncology | ||||||
| 03/16/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $95.95 | General |
| 11/30/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $98.17 | General |
| Category: Oncology | ||||||
| 05/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), XARELTO | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2017 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $19.02 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 72 | 5,612 | 88,822 | $5.0M | $1.0M |
| 2022 | 78 | 5,694 | 113,132 | $6.1M | $1.2M |
| 2021 | 90 | 7,168 | 283,460 | $10.9M | $2.3M |
| 2020 | 88 | 7,197 | 296,945 | $12.6M | $2.5M |
All Medicare Procedures & Services
328 procedure records from CMS Medicare Utilization — Page 1 of 14
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 16 | 13,200 | $1.9M | $571,926 | 29.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 4,440 | $308,580 | $80,993 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 605 | $182,613 | $54,087 | 29.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 74 | 339 | $282,885 | $34,421 | 12.2% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 15 | 13,900 | $291,900 | $32,531 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 273 | 308 | $55,609 | $17,851 | 32.1% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 25 | 10,790 | $97,110 | $14,832 | 15.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 567 | 1,919 | $67,165 | $14,583 | 21.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 100 | 208 | $42,332 | $12,755 | 30.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 79 | 982 | $103,110 | $11,731 | 11.4% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 11 | 62 | $61,132 | $11,051 | 18.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 408 | 891 | $55,242 | $9,194 | 16.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 312 | 652 | $37,816 | $8,686 | 23.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 19 | 152 | $37,872 | $8,544 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 57 | $21,580 | $7,568 | 35.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 35 | 149 | $60,661 | $7,507 | 12.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 385 | 818 | $15,542 | $6,863 | 44.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $22,041 | $6,453 | 29.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 169 | 223 | $54,189 | $6,444 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $23,492 | $5,956 | 25.4% |
| J1750 | Injection, iron dextran, 50 mg | Office | 2023 | 21 | 440 | $34,272 | $5,846 | 17.1% |
| 83550 | Iron binding capacity | Office | 2023 | 312 | 653 | $22,202 | $5,580 | 25.1% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 15 | 309 | $54,075 | $5,378 | 9.9% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 17 | 14,790 | $88,740 | $5,331 | 6.0% |
| 83520 | Measurement of substance using immunoassay technique | Office | 2023 | 78 | 308 | $55,748 | $5,213 | 9.4% |
About Dr. Cynthia Sile, MD
Dr. Cynthia Sile, MD is a Hematology & Oncology healthcare provider based in Suffolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568428043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cynthia Sile, MD has received a total of $486.10 in payments from pharmaceutical and medical device companies, with $26.22 received in 2022. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($288.33).
As a Medicare-enrolled provider, Sile has provided services to 25,671 Medicare beneficiaries, totaling 782,359 services with total Medicare billing of $7.0M. Data is available for 4 years (2020–2023), covering 328 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Suffolk, VA
- Active Since 04/25/2006
- Last Updated 06/19/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1568428043
Products in Payments
- ADCETRIS (Biological) $216.82
- OPDIVO (Biological) $98.17
- BOSULIF (Drug) $31.25
- XARELTO (Drug) $12.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Suffolk
Lauren Salmon, Do, DO
Hematology & Oncology — Payments: $6,908
Dr. Snehal Damle, M.d, M.D
Hematology & Oncology — Payments: $3,799
Hui Chen, M.d, M.D
Hematology & Oncology — Payments: $3,430
Ayham Deeb, M.d, M.D
Hematology & Oncology — Payments: $1,789
Daniel Atienza, Md, MD
Hematology & Oncology — Payments: $1,566
John Xie, Md, MD
Hematology & Oncology — Payments: $56.40